Related Experiment Video
Updated: Jun 7, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA-DQB1*06:02 Allele
Antti-Mathias Taka1,2, Taina Härkönen1, Paula Vähäsalo3,4
1Pediatric Research Center, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
Insights
The protective HLA DQB1*06:02 allele in type 1 diabetes is linked to older diagnosis age and higher GADA levels in children. This protective effect appears dominant, especially when combined with high-risk haplotypes.
Area of Science:
- Immunogenetics
- Pediatric Endocrinology
- Autoimmune Diseases
Background:
- Human Leukocyte Antigen (HLA) class II genes, particularly DQB1*06:02, play a role in autoimmune disease susceptibility.
- Understanding the influence of specific HLA alleles on type 1 diabetes (T1D) phenotype is crucial for risk stratification and management.
- Previous studies suggest DQB1*06:02 is protective against T1D, but its impact on clinical presentation at diagnosis requires further investigation in diverse populations.
Purpose of the Study:
- To investigate the clinical characteristics of pediatric type 1 diabetes at diagnosis in children carrying the protective HLA class II DQB1*06:02 allele.
- To compare T1D phenotypes between DQB1*06:02 carriers and non-carriers, including those with high-risk genotypes.
- To analyze the combined effect of the DQB1*06:02 allele and high-risk haplotypes on T1D presentation.
Main Methods:
- Observational study of 5530 Finnish children (0-14 years) diagnosed with T1D between 2003 and 2018.
- Comparison of clinical and autoantibody profiles (GADA, IA-2A) between 75 DQB1*06:02 carriers and non-carriers.
- Analysis of phenotypic differences based on the presence of DQB1*06:02 alone, in combination with high-risk haplotypes, or other HLA genotypes.
Main Results:
- DQB1*06:02 carriers were diagnosed at a significantly older age compared to non-carriers and those with high-risk genotypes (p < 0.001).
- Higher levels of glutamic acid decarboxylase autoantibodies (GADA) were observed in DQB1*06:02 carriers (p = 0.033).
- Pairing the DQB1*06:02-positive haplotype with a high-risk haplotype was associated with elevated islet antigen 2 autoantibodies (IA-2A) (p < 0.001) and shorter symptom duration (p = 0.043).
Conclusions:
- The protective DQB1*06:02 allele is associated with a later age of T1D diagnosis and increased GADA levels in pediatric patients.
- The phenotypic influence of the DQB1*06:02-positive haplotype appears to be dominant, particularly when co-inherited with a high-risk haplotype.
- These findings reinforce the role of specific HLA class II alleles in modulating T1D onset and presentation.
Abstract:
We set out to examine in an observational study characteristics of type 1 diabetes at the time of diagnosis among paediatric patients carrying the protective HLA class II DQB1*06:02 allele. We compared characteristics of type 1 diabetes among 5530 Finnish children aged 0-14 years diagnosed between 2003 and 2018. Seventy-five children with type 1 diabetes carried the DQB1*06:02 allele. The carriers of DQB1*06:02 allele were compared to all children with type 1 diabetes without this allele and those with a high-risk genotype. We also analysed, how does the genotype of a high-risk haplotype paired with DQB1*06:02 affect the phenotype of patients with newly diagnosed type 1 diabetes. Carriers of the DQB1*06:02 allele were diagnosed at an older age than those with any other HLA class II genotype (p = 0.003) or the high-risk genotype (p < 0.001). After adjusting the results for age and sex, no significant differences in clinical markers were observed. Glutamic acid decarboxylase autoantibody (GADA) levels were higher among carriers of DQB1*06:02 when compared to those with other genotypes (p = 0.033). Having a high-risk haplotype paired with DQB1*06:02-positive haplotype was associated with higher levels of islet antigen 2 autoantibodies (IA-2A) (p < 0.001) and somewhat shorter duration of symptoms (p = 0.043). The association between the protective DQB1*06:02 allele and an older age at diagnosis as well as higher levels of GADA at diagnosis of type 1 diabetes was confirmed. The effects of the DQB1*06:02-positive haplotype seem to dominate when paired with a high-risk haplotype.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Multiple Allele Traits
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...

